MS
Therapeutic Areas
Laigo Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Oncology Programs | Novel IO targets & intractable oncogenic drivers | Preclinical |
| Auto-immunity Programs | Autoimmune disease & graft rejection | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Oncology Programs | Novel IO targets & intractable oncogenic drivers | Preclinical |
| Auto-immunity Programs | Autoimmune disease & graft rejection | Preclinical |